Enteropathy induced by nonsteroid anti-inflammatory drugs


如何引用文章

全文:

作者简介

A Karateev

V Nasonova

参考

  1. Morris A., Wasson L., MacKenzie J. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 1992: 887- 889.
  2. Alison M., Howatson A., Torrance C. et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 1992; 327: 749-754.
  3. Vane J. R., Batting R. M., eds. Therapeutic role of selective COX-2 inhibitors. Cambridge; 2001.
  4. Davies N., Saleh J., Skjodt N. Detection and prevention of NSAID-induced enterophaty. S. Pharm. Sci. 2000; 3:137-155.
  5. Longman M., Morgan L., Worall A. Use of inflammatory drugs by patients admitted with small or large bowel perforations and hemorrhage. Br. Med. J. 1985; 290: 347-349.
  6. Kessler W., Shired G., Foney T. Surgical complications of nonsteroidal anti-inflammatory drug-induced small bowel unceration. J. Am. Coll. Surg. 1997; 185: 250-254.
  7. Campbell K., Steele R. Use of anti-inflammatory drugs and complicated diverticular disease: a case-control study. B. J. Surg. 1991; 78: 190-191.
  8. Lang J., Price A., Levi A. et al. Diaphragm disease: the pathology of non-steroidal anti-inflammatory drug induced small intestinal strictures. J. Clin. Pathol. 1988; 41: 516-526.
  9. Aabakken L. Small-bowel side-effects of non-steroidal anti-inflammatory drugs. Eur. J. Gastroenterol. Hepatol. 1999; 11: 383-388.
  10. Mowart A. Hematologic abnormalites in rheumatoid arthritis. Semin. Artht. Rheum. 1971; 4: 195-219.
  11. Bjarnason J., Prowse P., Smith T. et al. Blood end protein loss via small intestinal inflammation by non-steroidal anti-inflammatory drugs. Lancet 1987; 1: 711-714.
  12. Greenberg P., Cello J., Rockey D. et al. Relationship of lowdose aspirin to GI injury and occult bleeding: a pilot study. Gastrointest. Endosc. 1999; 50: 618-622.
  13. Hunt R., Bowen В., Mortensen E. et al. A randomized trial measuing fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subject. Am. J. Med. 2000; 109: 201-206.
  14. Tibbie J., Sigthorsson G., Foster R. et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999; 45: 362-366.
  15. Etienney I., Beaugerie L., Viboud C., Flahault A. Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study. Gut 2003; 52: 260-263.
  16. Chassany O., Michaux A., Bergmann J. Drug-induced diarrhoea. Drug Saf. 2000; 22: 53-72.
  17. Silverstein F., Faich G., Goldstein J. et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized controlled trial. J. A. M. A., 2000; 284: 12471255.
  18. Sigthorsson G., Jacob M., Wrigglesworth J. et al. Comparison of , indomethacin and nimesulide, a selective cyclooxygenase-2 in- 1 hibitor, on key pathophysiologic steps in the pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in the rat. Scand. J. Gastroenterol. 1998; 33: 728-735.
  19. Shah A., Thiodleifsson В., Murray F. et al. Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut 2001; 48: 339-346.
  20. Sigthorsson G., Crane R., Simon T. et al. COX-2 inhibition with rofecoxib does not encrease intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin. Gut 2000; 47: 527532.
  21. Evans S., Lasilo F., Whittle B. Site-specific lesion formation, inflammation and inducible nitric oxide synthase expression by indomethacin in the rat intestine. Eur. J. Pharmacol. 2000; 388: 281-285.
  22. Satoh H., Guth P., Grossman M. Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics. Gastroenterology 1983; 84: 483-489.
  23. Choudhry M., Fatal N., Namak S. et al. PGE2 suppresses intestinal T cell function in thermal injury: a cause of enhanced bacterial translocation. Shock 2001; 16: 183-188.
  24. Yamagiwa S., Yoshida Y., Haider R et al. Mechanisms involved in enteropathy induced by administration of nonsteroidal antiinflammatory drugs (NSA1DS). Dig. Dis. Sci. 2001; 46: 192-199.
  25. Reuter В. К., Wallace J. L. Phosphodiesterase inhibitors prevent NSAID enteropathy independently of effects on TNF-alpha release. Am. J. Physiol. 1999; 277: 847-854.
  26. Atchison C., West A., Balakumaran A. et al. Drug enterocyte adducts: possible causal factor fonatclofenac enteropathy in rats. Gastroenterology 2000; 119: 1537-1547.
  27. Mahmud Т., Somasundaram S., Sigthorsson G. et al. Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat. Gut 1998; 43: 775-782.
  28. Leite A., Sipahi A., Damiano A. et al. Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism. Gut 2001; 48: 163-167.
  29. Bassotti G., Bucaneve G., Furno P. et al. Double-blind, placebo-controlled study on effect of diclofenac sodium and indomethacin on postprandial gastric motility in men. Dig. Dis. Sci. 1998; 43: 1172-1176.
  30. Morris A., Murray L., Sturrock R. et al. Short report: the effect of misoprostol on the anemia of NSAID enteropathy. Aliment. Pharmacol. Ther. 1994; 8: 343-346.
  31. Hayllar J., Smith Т., Mapherson A. et al. Nonsteroidal anti-inflammatory drug-induced small intestinal inflammation and blood loss. Effect of sulfasalazine and other disease - modifying antirheumatic drugs. Arthr. and Rheum. 1994; 37: 1146- 1150.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Consilium Medicum, 2004

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


##common.cookie##